Background/Aims: Enriched environment (EE) has been reported to exert neuroprotective effect in animal models of ischemic stroke. However, the underlying mechanism remains unclear. The purpose of this study was to investigate the effect of EE treatment on neuronal apoptosis in the periinfarct cortex after cerebral ischemia/reperfusion (I/R) injury. Methods: The cerebral I/R injury was established by middle cerebral artery occlusion (MCAO). A set of behavioral tests including the modified neurological severity score (mNSS), limb-placing test and foot-fault test were conducted. The infarct volume and the neuronal survival rate were evaluated by Nissl staining. The morphology and ultrastructure of ischemic neurons was examined by transmission electron microscopy. Neuronal apoptosis was assessed by double labeling of TdT-mediated dUTP-biotin nick end labeling (TUNEL) with NeuN. The expressions of apoptosis-related proteins were tested by western blotting and immunohistochemical labeling. Results: EE treatment improved neurological function, reduced infarct volume, increased neuronal survival rate and alleviated the morphological and ultrastructural damage of neurons (especially mitochondria) after I/R injury. EE treatment reduced the neuronal apoptosis, increased B cell lymphoma/leukemia-2 (Bcl-2) protein levels while decreased Bcl-2-associated X protein (Bax), cytochrome c, caspase-3 expressions and Bax/Bcl-2 ratio in the periinfarct cortex after cerebral I/R injury. Conclusion: Our findings suggest that EE treatment inhibits neuronal apoptosis in the periinfarct cortex after focal cerebral I/R injury, which may be one of the possible mechanisms underlying the neuroprotective effects of EE.
Introduction
Cerebral ischemic stroke is a frequently occurring disease characterized by high mortality, morbidity, disability and reoccurrence [1] . Although significant advances in the technological and medical treatments have been made, many patients still suffer from varying degrees of dysfunction, which directly weaken their quality of life [2] . Therefore, it is extremely important to find effective strategies to improve the functional recovery of stroke patients.
Apoptosis is a form of programmed cell death characterized by cytoplasmic blebbing, chromatin condensation and DNA fragmentation [3] . It is essential in normal tissue development and homeostasis, while inappropriate or excessive apoptosis accelerates cell death [4] . After cerebral ischemia, the outer membrane of mitochondria becomes permeabilized, resulting in the release of cytochrome c from mitochondria intermembrane space to the cytoplasm, which subsequently activates caspase-3, and finally leads to DNA fragmentation [5] . This process of protein translocation and activation is mediated by the Bcl-2 family members such as antiapoptotic protein B cell lymphoma/leukemia-2 (Bcl-2) and proapoptotic protein Bcl-2-associated X protein (Bax) [6] . Human studies have suggested that patients with less apoptosis-positive cells in the penumbra were coupled with prolonged survival time [7] . Therefore, inhibition of apoptosis may be a promising strategy to promote poststroke recovery.
An enriched environment (EE) is an effective rehabilitative protocol for rodents, in which multiple animals are housed together in a large space equipped with different toys and receive more sensorimotor, cognitive and social stimulation compared with the standard conditions [8] . Mounting studies have suggested that exposure to EE treatment after brain injury leads to neuroprotective effects in animal models [9, 10] . Recently, EE treatment has been translated into a rehabilitation strategy for poststroke patients in the clinical setting [11] . The underlying mechanisms of EE treatment-induced neuroprotection after cerebral ischemia are multifaceted. Our previous study has demonstrated that EE treatmentinduced angiogenesis contributed to the improved functional recovery of stoke animals [12] . However, whether the neuroprotective effect of EE treatment is associated with the reduction of neuronal apoptosis in the periinfarct cortex has not been reported.
In the present study, we investigated the effect of EE treatment on neuronal apoptosis in the periinfarct cortex after cerebral ischemia/reperfusion (I/R) injury. We examined neurological deficits and infarct volume. We performed transmission electron microscope to determine the morphology and ultrastructure of neurons in the periinfarct area of cortex. We tested neuronal apoptosis in the periinfarct cortex using double immunofluorescent staining of TUNEL with NeuN. The immunostaining and western blot were also employed to determine the protein levels of Bcl-2, Bax, cytochrome c and caspase-3 in the periinfarct cortex at 14 days after cerebral I/R injury.
Materials and Methods

Animals
Male Sprague-Dawley (SD) rats weighing 200-240g were purchased from Hunan SJA Laboratory Animal Co., Ltd (SCXK (Xiang 2013-0004)). All rats were housed in a controlled condition (4 animals per cage, 22-25°C, 50-60% relative humidity, 12 h light/dark cycle) with free access to water and standard rat chow for 3 days to adapt to the laboratory environment before receiving operation. All experimental procedures were performed under the Guidance Suggestion for the Care and Use of Laboratory Animals. The experimental protocol for this research was approved by the Institutional Animal Care and Use Committee of Wuhan University, China. All efforts were made to reduce the mortality of animals and their suffering.
Groupings and housing conditions
Animals were randomly divided into 3 groups: sham group (sham-operated rats housed in standard condition), I/R group (middle cerebral artery occlusion (MCAO) rats housed in standard condition), or EE group (MCAO rats housed in EE). Twenty-four hours after MCAO, rats in EE group went to EE cages, which were 90 cm long × 75 cm wide × 50 cm high with wire mesh lids containing climbing ladders, chains, different shaped tubes, plastic tunnels, colored blocks and a running wheel to provide sensorimotor stimulations. EE also provided enhanced social stimulation by housing 6-8 rats together in one cage. The contents were changed daily to promote novelty and exploration. Rats in I/R and sham groups were housed in standard cages (44 cm long × 32 cm wide × 20 cm high) with no objects, 4 rats per cage.
MCAO model
All rats received right MCAO as previously described [13] . A total of 60 healthy adult male SD rats were anesthetized using isoflurane administered through a face mask. A midline incision about 2 cm was made in the neck skin, and the right carotid artery (CCA), external carotid artery (ECA), and internal carotid artery (ICA) were carefully isolated. After that, a monofilament nylon filament (Beijing Cinontech Biotech Co., Ltd., Beijing, China) was inserted through the right CCA and gently advanced into the ICA to a point about 18 mm distal to the bifurcation of the carotid artery, the right MCA was then occluded. 2 h later, the filament was gently withdrawn for reperfusion. Rats in sham group received the same surgical procedures except inserting a nylon filament. During the surgery, seven rats (three in sham group, two in I/R group and two in EE group) died of excessive bleeding and vagus nerve cut off. After recovering from anesthesia, the neurologic results were scored on a five-point scale and the rats were excluded from the study with a score of 0 or 4 [14] . Rats with scores of 1-3 were considered successful models and included in the study. Five rats (two in I/R group and three in EE group) with scores of 0 or 4 were excluded. During the following two weeks, six rats (three in sham group, two in I/R group and one in EE group) died at the first three days and no more death after that. Finally, forty-two rats were included in this study, and the number of rats in each group was fourteen.
Behavioral tests
The mNSS was performed at 3, 7, 14 days after stroke by an investigator who was blinded to the experimental groups [15] . It is a composite of motor, sensory, reflex and balance tests. The total score is 18, which indicates the most severe injury. One score point is scored for failure to perform the test or the lack of a tested reflex. Thus, a higher score indicates a more severe injury.
Foot-fault test was utilized as a measure of motor impairment which was widely used after stroke [16] . The test consists of free movement on a grid-like surface for 5 min. When a rat places the limbs incorrectly on the grid, the limb falls through and is counted as a fault. The test was conducted post-operative days 3, 7, and 14. Tests were always performed twice and means were used for statistical analysis.
Limb-placing test was used to assess the sensorimotor integration of forelimb and hindlimb responses to tactile and proprioceptive stimulation, which consists of seven limb-placing tasks [17] . The tasks were scored as follows: 2 points: the rat performed normally; 1 point, the rat performed with a delay (2 s) and/or incompletely; 0 points, the rat did not perform normally. Both sides of the body were included. All rats were pre-trained on these tests for three days before ischemia induction.
Nissl staining
Rats (n = 6 per group) were deeply anesthetized using an intraperitoneal injection of chloral hydrate at 14 days after MCAO and then transcardially perfused with 200 mL of 0.9% saline followed by 200 mL of 4% paraformaldehyde solution. The brain tissues were harvested and postfixed in paraformaldehyde overnight. Thereafter, 20-μm thick coronal sections with the distance between adjacent sections of 400 μm were collected for Nissl staining.
The procedure was carried out as previously described [18] . Brain sections were immersed in 0.1% cresyl violet for 40 min at 60°C and then rinsed in distilled water for 10 min. Stained sections were fixed by serial dehydration in alcohol and xylene before cover slipping with mounted medium. The infarct region was defined as containing dark pyknotic necrotic cell bodies or reduced staining. To minimize the effect of edema and liquefaction resulting from infarction, the infarct area in each section was calculated as: contralateral hemisphere area -ipsilateral non-infarct area. Infarct volume between two adjacent sections was calculated by the formula: 1/3×h (S1 + S2 + ), S1 and S2 were the infarct areas of two sections, and h was the distance between them [19] . The total infarct volume was derived from the sum of all infarct volume between each adjacent section. At last, the percentage of infarct volume was calculated as: total infarct volume/total contralateral hemispheric volume × 100%.
Chen et al.: Enriched Environment Reduces Neuronal Apoptosis in Rats
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
For counting the number of viable neurons, four random views in each section were measured per rat using a light microscope (Olympus Corporation, Tokyo, Japan) at × 200 magnification and the number of survival neurons was quantified with Image Pro Plus 6.0 (Media Cybernetics Inc., Bethesda, MD, USA) by an observer without knowledge of the experiment. Only orderly arranged cells had normal morphology with abundant cytoplasm and evident nucleus and nucleolus were considered as survival neurons and included.
Transmission electron microscopy Fourteen days after MCAO, fresh brain tissues (n = 2 per group) were taken from the periinfarct cortical area, cut into small pieces of 1 mm × 1 mm × 1 mm and fixed in 2.5% glutaraldehyde overnight at 4°C. Then, specimens were rinsed with PBS and soaked in osmium tetroxide. After dehydration in acetone, specimens were embedded in epoxide resin and 70 nm thick sections were prepared. After that, species were put onto copper grids and stained with uranyl acetate followed by lead citrate. At last, cellular and ultrastructural changes of neurons were observed and photographed by transmission electron microscope (HT7700, Hitachi, Japan).
TUNEL staining
To evaluate neuronal apoptosis in the periinfarct cortex, double immunofluorescent staining of the TdT-mediated dUTP-biotin nick end labeling (TUNEL) with NeuN was performed. The paraffin sections (4 μm thick) were incubated overnight at 4°C with anti-NeuN antibody (1:150, Abcam, Cambridge, UK), followed by incubation with Cy3-conjugated goat anti-mouse IgG secondary antibodies (1:50, Aspen Biotechnology, Hubei, China) for 50 min at room temperature. TUNEL staining was performed using an in situ cell death detection kit (Roche, Basel, Switzerland) following the manufacturer's protocol [20] . At last, the sections were covered with 4'6-diamidino-2-phenylindole (DAPI) (Aspen Biotechnology, Hubei, China). In this study, four random fields in the penumbra of ischemic cortex were captured in each section with a fluorescence microscope (Olympus Corporation, Tokyo, Japan). The number of stained cells per field was calculated under higher magnification (200 ×) by an investigator blinded to experiment design.
Western blot
The experimental rats were euthanized and the periinfarct cortical tissues (n = 6 per group) were removed at 14 days post-MCAO for western blot analysis as previously described [21] . The concentration of proteins was determined by using a protein assay kit (Bio-Rad, USA). 40 μg proteins were electrophoresed on SDS-PAGE gels and then transferred onto polyacrylamide difluoride (PVDF) membrane (Millipore, Massachusetts, USA). Membranes were incubated with respective primary antibodies (anti-Bax, 1:1500, CST; anti-Bcl-2, 1:1000, Abcam; anti-cytochrome c, 1:1500, CST; anti-caspase-3, 1:1000, Abcam) overnight at 4°C, followed by incubation with horseradish peroxidase (HRP)-conjugated goat anti-rabbit (1:10000, KPL, USA) or goat anti-mouse IgG secondary antibodies (1:10000, KPL, USA) for 30 min at room temperature. Protein bands were visualized by an enhanced chemiluminescence system (ECL kit, Aspen Biotechnology, Hubei, China). Quantification of band intensity (optical density) was analyzed using AlphaEaseFC software (Alpha Innotech, California, USA). GAPDH served as loading condition.
Immunohistochemistry and Immunofluorescence
Brain paraffin sections (4μm) were incubated overnight at 4°C with rabbit polyclonal anti-Bcl-2 antibody (1:200, Abcam, Cambridge, UK) and rabbit monoclonal anti-Bax antibody (1:200, Abcam, Cambridge, UK) respectively. After three times rinses (5 min each) with phosphate-buffered saline (PBS, pH=7.4), the sections reacted with goat anti-rabbit IgG conjugated to peroxidase secondary antibody (1:200, Aspen Biotechnology, Wuhan, China). The remaining procedures were according to the standard procedures [22] . Negative controls were established to investigate the specificity of the reactions. For semi-quantitative analysis, four visual fields (200 ×) from each section in periinfarct area were photographed under a light microscope (Olympus Corporation, Tokyo, Japan), and integrated optical density (IOD) was analyzed using Image Pro Plus 6.0 (Media Cybernetics Inc., Bethesda, MD, USA).
The immunofluorescent staining was used to assess the expression of caspase-3. Brain sections were then incubated overnight with rabbit polyclonal anti-caspase-3 antibody (1:200, Abcam, Cambridge, UK). After being rinsed with PBS, the tissues were incubated with Cy3-conjugated goat anti-rabbit IgG secondary antibody (1:50, Aspen Biotechnology, Wuhan, China). The unspecific labeling was found by replacing the primary antibody with PBS.
Results
EE treatment improves neurological function in stroke animals
To determine whether EE treatment promoted functional recovery of stroke rats, a series of tests including the mNSS, foot-fault test and limb-placing test were performed. The ischemic rats (EE and I/R) showed worse performance compared to the sham group on all three behavioral tests at various time points after MCAO (Fig. 1A-C) . The mNSS scores of sham group at each time point were zero (Fig. 1A) . No difference was found between the EE and I/R groups on day 3 (Fig. 1A) . However, rats in EE group showed lower mNSS scores than those in I/R group at 7 and 14 days after MCAO (Fig. 1A) . The EE group had significant less left forefoot faults (Fig. 1B) and improved performance of limb placement (Fig. 1C ) at 7 and 14 days after MCAO compared to the I/R group. Taken together, these findings suggest that EE treatment improves neurological functional recovery of stroke animals.
Fig. 1. EE treatment improves neurological deficits at 3, 7 and 14 days after MCAO. Quantitative analysis of mNSS (A), foot-fault test (B) and limb-placing test (C)
. Data were expressed as mean ± SD, n = 14/group. # P < 0.05 vs sham group, *P < 0.05 vs I/R group.
EE treatment reduces infarct volume and increases neuronal survival
As the improved functional outcome might be ascribed to the reduced brain damage, cerebral infarct volume was evaluated by Nissl staining at 14 days after MCAO (Fig. 2A) . The results showed that EE treatment significantly reduced infarct volume compared to I/R group ( Fig. 2A) . No lesion was found in the sham group.
We further observed the number of viable neurons in the periinfarct cortex. In I/R group, most of the neurons in the periinfarct cortex were shrunk, deeply stained and sparsely distributed with cytosolic concentration, karyopyknosis and karyorrhexis (Fig. 2B ), which were seldom observed in EE group. While the number of viable neurons, which were orderly arranged with normal morphology and evident nucleus and nucleolus, was significantly increased in EE group (Fig. 2B) . In sham group, normal neurons were orderly arranged with normal morphology and evident nucleus and nucleolus (Fig. 2B) . These results suggest that EE treatment reduces brain damage induced by cerebral I/R injury.
EE treatment protects against cerebral I/R injury-induced alterations of neuronal morphology and ultrastructure in the periinfarct cortex
In order to determine EE treatmentinduced the stabilization of neuronal morphology and ultrastructure in the periinfarct cortex, transmission electron microscope was performed. Normal cortical neurons had large oval nucleus with clear nuclear membrane, even chromatin (Fig. 3A) and normal mitochondria (Fig. 3D) . While in I/R group, neurons had irregular nuclear membrane, chromatin condensation, many vacuole (Fig. 3B)   Fig. 2 , P < 0.05). Data were presented as mean ± SD, n = 6/group. # P < 0.05 vs sham group, *P < 0.05 vs I/R group. 
and swollen mitochondria (Fig. 3E) . By contrast, the above changes were alleviated in EE group ( Fig. 3C and 3F ). These results indicate that EE treatment alleviates neurons damage.
EE treatment decreases neuronal apoptosis in the periinfarct cortex
To directly clarify whether EE treatment reduced neuronal apoptosis in the periinfarct cortex and locate the apoptotic neurons, the double labeling of TUNEL with NeuN was conducted at 14 days after MCAO. A large number of TUNEL-positive neurons were observed in the periinfarct cortex of ischemic rats (I/R and EE), whereas TUNEL-positive neurons were seldom detected in sham group (Fig. 4A) . EE treatment significantly decreased the number of TUNEL-positive neurons and the apoptosis ratio of neurons compared to I/R group ( Fig. 4B and 4C ). These findings supported the inhibitory effect of EE treatment on neuronal apoptosis.
EE treatment regulates the expressions of apoptosis-related proteins
To further investigate how EE treatment inhibited neuronal apoptosis in the periinfarct cortex, we tested the expression levels of antiapoptotic protein B cell lymphoma/leukemia-2 (Bcl-2), proapoptotic protein Bcl-2-associated X protein (Bax), cytochrome c and caspase-3 in the periinfarct cortex at 14 days after MCAO. Western blot results showed that Bcl-2 protein levels were significantly increased following the EE treatment, while Bax, cytochrome c and caspase-3 expressions were decreased (Fig. 5A-D) . Moreover, the ratio of Bax/Bcl-2 in the EE group was obviously decreased when compared with I/R group (Fig. 5F ).
Our immunohistological data suggested that Bcl-2, Bax and caspase-3 were mainly expressed in neurons (Fig. 6A) , implicating that neuronal apoptosis accounts for the major portion of apoptosis. Rats in EE group showed higher expression levels of Bcl-2 and lower expression levels of Bax and caspase-3 than those in I/R group (Fig. 6B) . These results suggest that EE treatment inhibits neuronal apoptosis via regulating apoptosis-related proteins expression in the periinfarct cortex following cerebral I/R injury. was the first to investigate the effect of EE treatment on neuronal apoptosis in the periinfarct cortex in a MCAO rat model. Our data showed that EE treatment reduced neuronal apoptosis in the periinfarct cortex, increased Bcl-2 protein levels while decreased Bax, cytochrome c and caspase-3 expressions following cerebral I/R injury. Furthermore, EE treatment improved neurological function of stroke animals, reduced infarct volume, increased the number of viable neurons and alleviated morphological and ultrastructural damage of neurons. Our findings suggest that reduction of neuronal apoptosis in the periinfarct cortex induced by EE treatment may be one of the possible mechanisms underlying its neuroprotective effect.
While most of the studies which tried to elucidate the possible mechanisms underlying the neuroprotective effect of EE treatment have focused on neurogenesis [23] , synaptogenesis [24, 25] or angiogenesis [12] , the importance of neuron survival has been neglected. As apoptosis is one of the major causes that lead to cell death after I/R injury especially in the periinfarct cortex [26] , suppressing apoptosis may be an effective way to improve the survival rate of neurons and eventually benefit the prognosis after stroke. Previous studies have demonstrated that cellular apoptosis can be inhibited by medicines or stem cell transplantation in animal models of cerebral ischemia [27] [28] [29] . This study for the first time evaluated EE treatment-induced inhibition of neuronal apoptosis in the periinfarct cortex after cerebral I/R injury, which offered a new insight into the underlying mechanism of EE's neuroprotective effect.
Two general pathways including the extrinsic and intrinsic pathways are involved in the apoptotic process. The intrinsic pathway is closely related with the mitochondria which plays an important role in cell events including energy metabolism, cell differentiation and generation of reactive oxygen species (ROS) [5, 30] . Cerebral ischemia disrupts the normal state of electrochemical gradient in mitochondrial membrane, which is essential for normal function of mitochondria [31] . Damaged mitochondria could release cytochrome c to the cytoplasm, leading to the apoptosis [32] . Therefore, any strategy that can maintain the structural integrity of mitochondria, promote mitochondrial biogenesis and prevent mitochondrial dysfunction may have the potentiality to inhibit apoptosis. Previous study has shown that exercise could induce mitochondrial biogenesis by increasing the expression of mitochondrial biogenesis factors and mitochondrial protein after experimental stroke [33] . Further study indicated that exercise might improve mitochondrial function in the ischemic brain by preventing mitochondrial fission and promoting mitochondrial fusion [34] . In our study, results from transmission electron microscope showed that treatment with EE significantly alleviated the damage of mitochondria, suggesting that EE treatment may provide neuroprotective effect through maintaining the structural integrity of mitochondria.
Our data showed that EE treatment reduced neuronal apoptosis in the periinfarct cortex caused by cerebral I/R injury, which could be mediated by the mitochondrialdependent pathway. Bcl-2 family proteins are pivotal moderators of apoptosis, which play an important role in maintaining mitochondrial stabilization [35] . The binding of Bcl-2 and Bax could prevent the pore formation on the outer membranes of mitochondria, reduce the release of cytochrome c, inhibit the formation of the apoptosome and thus inhibit activation of caspase family [36] . Previous studies have shown that both passive and pre-ischemic exercise suppressed the apoptosis and reduced neurons loss in the periinfarct area via upregulating expression of Bcl-2 and maintaining the balance ratio of Bax/Bcl-2 [37] [38] [39] . Except for Bcl-2 family, caspase-3 is one of the most important downstream executors in the mitochondrial apoptotic pathway, which is considered as an indicator of neuronal apoptosis [40] . Previous studies have demonstrated that deletion and inhibition of caspase-3 provided neuroprotection through mediating neuronal death and rendering neurons resistant to ischemic injury in vivo and in vitro [41] . In the present study, we showed that EE treatment increased Bcl-2 protein levels, decreased Bax expression and Bax/Bcl-2 ratio. Furthermore, EE treatment inhibited the release of cytochrome c from the mitochondria to cytoplasm and thus prevented the activation of caspase-3. Although the mechanism of EE treatmentinduced inhibition of neuronal apoptosis needs to be further investigated, our present study suggests that the mitochondrial pathway may be an important target underlying this.
